CMS Proposes New Guidelines for Reporting and Refunding Medicare Overpayments

BACK TO INSIGHTS     Articles

8/31/2024

On July 10, 2024, the Centers for Medicare & Medicaid Services (CMS) issued the 2025 Medicare Physician Fee Schedule Proposed Rule which, among other things, proposes amendments to deadlines for reporting and returning Medicare Part A and Part B overpayments.

Specifically, CMS is proposing more lenient deadlines for reporting and returning overpayments, giving providers more time to investigate and calculate overpayments. The Proposed Rule, if adopted, would suspend the 60-day period for reporting an overpayment if an overpayment is identified but a good-faith investigation to uncover related overpayments has not been completed. This pause would last until the earlier of either (i) the completion of the investigation and calculation of related overpayments or (ii) 180 days from the initial identification of the overpayment. The pause would also apply if a provider makes a submission to the Office of the Inspector General (OIG) Self-Disclosure Protocol, the CMS Voluntary Self-Referral Disclosure Protocol, or requests an extended repayment schedule. Once the suspension ends, the requirement to report and return the overpayment would occur within either (i) 60 days after concluding the investigation and calculating the overpayment or (ii) 180 days from the initial discovery of the overpayment.

CMS provided the following example of how the suspension of the deadline would operate: If a provider identifies an overpayment and suspects additional related claims, the provider would have up to 180 days from discovery of the overpayment to conduct a good-faith investigation. This period could be extended further under certain conditions, such as making voluntary submissions to the OIG or CMS. However, if the provider decides not to investigate further, the overpayment must be reported and returned within 60 days of the initial discovery.

Click Here to read the entire August 2024 Healthcare Law Update now!

For more information, contact:
John D. Fanburg, Chair | 973.403.3107 | jfanburg@bracheichler.com
Edward J. Yun | 973.364.5229 | eyun@bracheichler.com
Vanessa Coleman | 973.364.5208 | vcoleman@bracheichler.com

*This is intended to provide general information, not legal advice. Please contact the authors if you need specific advice.

John D. Fanburg

Managing Member
Healthcare Law, Cannabis Industry

973.403.3107 · 973.618.5507 Fax

Related Practices:   Healthcare Law

Related Industry:   Healthcare